We are live on ! Find out more
AHS

Aspiriant Holdings S3 Portfolio holdings

AUM $233M
1-Year Est. Return 3.13%
This Fund
S&P 500
This Quarter Est. Return
+8.52%
1 Year Est. Return
-3.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$254M
AUM Growth
+$17.5M
Cap. Flow
-$1.13M
Cap. Flow %
-0.44%
Top 10 Hldgs %
25.16%
Holding
107
New
5
Increased
27
Reduced
66
Closed
1

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$3.33M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$663K
3
GLD icon
SPDR Gold Trust
GLD
+$548K
4
EMC
EMC CORPORATION
EMC
+$316K
5
AAPL icon
Apple
AAPL
+$171K

Sector Composition

Rank Sector Weight
1 Financials 13.36%
2 Technology 11.58%
3 Healthcare 9.15%
4 Communication Services 8.21%
5 Energy 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMT icon
101
American Tower
AMT
$81.7B
$219K 0.09%
2,739
IXP icon
102
iShares Global Comm Services ETF
IXP
$577M
$217K 0.09%
3,179
-140
-4% -$9.42K
VEA icon
103
Vanguard FTSE Developed Markets ETF
VEA
$234B
$212K 0.08%
+5,095
New +$207K
AXP icon
104
American Express
AXP
$234B
$208K 0.08%
+2,296
New +$189K
HMC icon
105
Honda
HMC
$39.1B
$207K 0.08%
+5,000
New +$202K
XLU icon
106
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
$201K 0.08%
10,580
-2,400
-18% -$45.9K
TEVA icon
107
Teva Pharmaceuticals
TEVA
$40.1B
-17,555
Closed -$663K

Similar funds

Aspiriant Holdings S3's Q4 2013 Portfolio in Review

As of Q4 2013, Aspiriant Holdings S3 held 107 positions worth $254M, up 7.4% from $237M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Aspiriant Holdings S3's Q4 2013 filing shows 5 new, 27 increased, 66 reduced and 1 closed positions. Its largest new stake was Comcast: 157,448 shares worth $4.09M. The largest sale was IBM, an estimated $3.33M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

  • Aspiriant Holdings S3's largest Q4 2013 buy was Comcast: 157,448 shares worth $4.09M.
  • Aspiriant Holdings S3 added most to Vanguard S&P 500 ETF in Q4 2013, an estimated $365K increase.
  • Aspiriant Holdings S3's biggest Q4 2013 reduction was IBM, cutting an estimated $3.33M.
  • Aspiriant Holdings S3 fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $663K.
  • Aspiriant Holdings S3's ten largest holdings make up 25% of its $254M portfolio in Q4 2013.
  • Aspiriant Holdings S3 opened 5 new positions and closed 1 in Q4 2013.
  • Aspiriant Holdings S3's portfolio value rose 7.4% quarter-over-quarter to $254M.

Based on Aspiriant Holdings S3's 13F filing for Q4 2013, filed 3 Feb 2014.